M 447 (Benazepril 40 mg)
Pill imprint M 447 has been identified as Benazepril hydrochloride 40 mg.
Benazepril is used in the treatment of diabetic kidney disease; high blood pressure; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M 447
- Strength:
- 40 mg
- Color:
- White
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0447
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
crospovidone
hypromelloses
polydextrose
polyethylene glycol
corn starch
stearic acid
magnesium silicate
titanium dioxide
triacetin
More about benazepril
Consumer resources
- Other brands: Lotensin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
